Navigation Links
West Pharmaceutical Services Issues Statement on Exubera
Date:10/18/2007

LIONVILLE, Pa., Oct. 18 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today provided comments related to Pfizer, Inc.'s announcement that it has decided to discontinue marketing the Exubera Inhalable Insulin product, returning the marketing rights to the Company's customer, Nektar Therapeutics, Inc. The Company's Tech Group is one of two companies that produce the Exubera inhalation device for Nektar.

"We were surprised and disappointed by Pfizer's announcement today and are in the process of evaluating its impact on the Company," said Donald E. Morel, Jr. Ph.D., West's Chairman and Chief Executive Officer. "The actual effects on our business will depend on how Nektar decides to proceed in the wake of this change. We will continue to work with and support Nektar as they evaluate their options."

The Company's investments related to the Exubera project include approximately $15 million of current assets and production facilities, which it believes are fully recoverable, and approximately $13 million of intangible assets. Pfizer's decision is not expected to impact the Company's results for the third quarter ended September 30, 2007 or its earnings per share guidance for the full year of $2.27 to $2.37 per diluted share, excluding, as previously disclosed, discrete tax items and now excluding the effects of any impairment to its intangible assets associated with the Exubera business. The potential for an asset impairment will be evaluated based on information, as it becomes available, concerning Nektar's plans for Exubera and for the Company's role in those plans.

The Company will provide any further updates on this situation and to discuss the results of operations and its bus
'/>"/>

SOURCE West Pharmaceutical Services, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. South Africa Wins landmark case against pharmaceutical giants
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Setting up a new pharmaceutical industry in India
5. Medicis Pharmaceutical company enters pediatric market
6. Supply of Radiopharmaceuticals Hampered by Attacks
7. Pharmaceutical companies are targeting patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... evidence mounts showing the potential health benefits of probiotics, ... are taking supplements. And the chemical industry is getting ... health effects could deter growth, so the industry is ... according to the cover story in Chemical & ... the American Chemical Society. , Melody M. Bomgardner, a ...
(Date:4/23/2014)... a country as wealthy as the United States, it may ... not have access to adequate food due to lack of ... , Recent research at the University of Illinois using data ... that the seniors who are dealing with hunger are also ... 8.35 percent of Americans over age 60 faced the threat ...
(Date:4/23/2014)... team of scientists led by a researcher from the ... National University of Singapore has identified the cancer specific ... up the possibility of developing new drugs for the ... , The research group, led by Dr Chan Shing ... the first time that a cancer-specific variant of a ...
(Date:4/23/2014)... Physical Activity on Mobility Limitation in Old Age , ... of mobility limitation in old age, whereas leisure-time physical ... study which followed up 5,200 public sector employees for ... Research Center in Finland and the Finnish Institute of ... wears the body and lasts for several hours a ...
(Date:4/23/2014)... may prevent the depletion of self-control, according to research ... the Association for Psychological Science. , Self-control can be ... focus attention on a boring textbook are hard things ... this difficulty: Exerting self-control for a long period seems ... subsequent tasks. , "It is as if self-control is ...
Breaking Medicine News(10 mins):Health News:More Americans in their golden years are going hungry 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2Health News:ADHD drug may help preserve our self-control resources 2
... , The poll results come on the heels ... WASHINGTON, Aug. 7 A poll conducted by the American Red ... against the H1N1 virus, more than a third of parents (39%) have received ... (Logo: http://www.newscom.c o m/cgi-bin/prnh/20090108/RedCrossLOGO ...
... , WHEATON, Ill., Aug. 7 ... Hospital a grant in the amount of $15,000. The grant ... offers group classes for children with physical or developmental disabilities ... and improve their motor, sensory, play, communication and social skills, ...
... describes families as untapped resource in prevention efforts, , FRIDAY, ... child may be the victim of medical errors while in ... survey of 278 parents of children hospitalized in 2005 at ... watch over their child,s care to ensure there were no ...
... Emory University, believe conventional vaccine strategies should not be ... effective AIDS vaccine. Based on studying simian immunodeficiency viruses ... new approach to the AIDS vaccine research agenda in ... Nature Medicine . Their recommendations outline specific research priorities ...
... who excel at processing new information at 6- ... achievements as young adults in their 20,s, ... University Psychologist Joseph Fagan. Fagan,s "The prediction, from ... journal Intelligence , is receiving accolades. Mensa International, ...
... communication of the outcomes of medical tests whose results ... discharge is common and can lead to serious medical ... study by researchers from the Regenstrief Institute and the ... discharge summaries are grossly inadequate at documenting both tests ...
Cached Medicine News:Health News:Red Cross Poll Shows Parents Still Lack H1N1 Information From Schools 2Health News:DuPage Community Foundation Awards $15,000 Grant to Marianjoy Pediatric Continuing Care Program 2Health News:DuPage Community Foundation Awards $15,000 Grant to Marianjoy Pediatric Continuing Care Program 3Health News:When Kids Are Hospitalized, Parents Fret About Errors 2Health News:Yerkes researchers propose ambitious new strategies for AIDS vaccine research 2Health News:Yerkes researchers propose ambitious new strategies for AIDS vaccine research 3Health News:Ability to process information as a baby continues into adulthood 2Health News:Fumbled handoffs can lead to medical errors 2
(Date:1/15/2014)... 15, 2014 The Cadence Fitness & Health Center ... the Medical Fitness Association, a non-profit organization assisting medically ... potential. The Cadence Fitness & Health Center is the ... second in the Chicagoland area. "The certification ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: PharmaPoint: ... Market Analysis to 2022 ... - India Drug Forecast and Market Analysis ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... market research report is available in ... Global Markets and Technologies for Advanced ... Routes of Administration ...
Breaking Medicine Technology:Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
... THE OHIO STATE UNIVERSITY ... CENTER JOINS PHASE III TRIAL FOR METASTATIC MELANOMA ... (Nasdaq: DCTH ) announced today that The Ohio ... Research Institute has joined Delcath,s Phase III clinical trial for the treatment ...
... online this week in the Journal of Clinical ... selective estrogen receptor modulator (SERM) being developed by Eli ... increased lumbar spine and total hip bone mineral density ... mass, versus placebo.In addition, arzoxifene, dosed at 20 mg/day, ...
Cached Medicine Technology:Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM) 2Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM) 3Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density 2Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density 3Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: